Vascular endothelial growth factor stimulates skeletal muscle regeneration in Vivo

Molecular Therapy

Volumn 10, Issue 5, 2004, Pages 844-854

  Arsic, Nikola ^a   Zacchigna, Serena ^a   Zentilin, Lorena ^a   Ramirez Correa, Genaro ^a   Pattarini, Lucia ^a   Salvi, Alessandro ^b   Sinagra, Gianfranco ^a   Giacca, Mauro ^a,c  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c CNR   (Italy)

Author keywords

Adeno associated virus; Gene therapy; Muscle; Vascular endothelial growth factor; Vascular endothelial growth factor receptor 2

Indexed keywords

AMINO ACID; CARDIOTOXIN; COMPLEMENTARY DNA; GLYCEROL; ISOPROTEIN; PARVOVIRUS VECTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GENE TARGETING; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE CELL; MUSCLE DISEASE; MUSCLE FIBRIL; MUSCLE GROWTH; MUSCLE INJURY; MUSCLE ISCHEMIA; MUSCLE REGENERATION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; UPREGULATION;

ANIMALS; APOPTOSIS; CYTOTOXINS; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; GLYCEROL; ISCHEMIA; MICE; MUSCLE FIBERS; MUSCLE, SKELETAL; MYOBLASTS; NECROSIS; REGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ADENO-ASSOCIATED VIRUS;

EID: 7044235846     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.08.007     Document Type: Article

References (49)

1. G.D. Yancopoulos S. Davis N.W. Gale J.S. Rudge S.J. Wiegand J. Holash Vascular-specific growth factors and blood vessel formation Nature 407 2000 242-248
2. N.W. Gale G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev. 13 1999 1055-1066
3. N. Ferrara H.P. Gerber J. LeCouter The biology of VEGF and its receptors Nat. Med. 9 2003 669-676
4. D. Lambrechts et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat. Genet. 34 2003 383-394
5. K. Jin Y. Zhu Y. Sun X.O. Mao L. Xie D.A. Greenberg Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo Proc. Natl. Acad. Sci. USA 99 2002 11946-11950
6. K.L. Jin X.O. Mao D.A. Greenberg Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia Proc. Natl. Acad. Sci. USA 97 2000 10242-10247
7. P. Schratzberger et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy Nat. Med. 6 2000 405-413
8. J. LeCouter et al. Angiogenesis-independent endothelial protection of liver: Role of VEGFR-1 Science 299 2003 890-893
9. E. Zelzer et al. Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis Development 129 2002 1893-1904
10. M.M. Deckers M. Karperien C. van der Bent T. Yamashita S.E. Papapoulos C.W. Lowik Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation Endocrinology 141 2000 1667-1674
11. U. Mayr-Wohlfart et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts Bone 30 2002 472-477
12. J. Street et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover Proc. Natl. Acad. Sci. USA 99 2002 9656-9661
13. A. Ishida et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells J. Cell. Physiol. 188 2001 359-368
14. Z. Wang M.R. Castresana W.H. Newman Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells Biochem. Biophys. Res. Commun. 285 2001 669-674
15. B. Barleon S. Sozzani D. Zhou H.A. Weich A. Mantovani D. Marme Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336-33343
16. H.P. Gerber et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism Nature 417 2002 954-958
17. D. Lyden et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth Nat. Med. 7 2001 1194-1201
18. R.O. Snyder et al. Efficient and stable adeno-associated virus-mediated transduction in the skeletal muscle of adult immunocompetent mice Hum. Gene Ther. 8 1997 1891-1900
19. S. Bouchard et al. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice J. Gene Med. 5 2003 941-950
20. N. Chirmule K. Propert S. Magosin Y. Qian R. Qian J. Wilson Immune responses to adenovirus and adeno-associated virus in humans Gene Ther. 6 1999 1574-1583
21. N. Arsic et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors Mol. Ther. 7 2003 450-459
22. T.T. Rissanen et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration Am. J. Pathol. 160 2002 1393-1403
23. A. Germani et al. Vascular endothelial growth factor modulates skeletal myoblast function Am. J. Pathol. 163 2003 1417-1428
24. K.J. Fisher et al. Recombinant adeno-associated virus for muscle directed gene therapy Nat. Med. 3 1997 306-312
25. M. Autiero et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 Nat. Med. 9 2003 936-943
26. P. Carmeliet et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat. Med. 7 2001 575-583
27. M.L. Springer et al. Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle Mol. Ther. 7 2003 441-449
28. M.L. Springer A.S. Chen P.E. Kraft M. Bednarski H.M. Blau VEGF gene delivery to muscle: Potential role for vasculogenesis in adults Mol. Cell 2 1998 549-558
29. K. Hattori et al. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells J. Exp. Med. 193 2001 1005-1014
30. T. Asahara et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J. 18 1999 3964-3972
31. E. Gussoni et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation Nature 401 1999 390-394
32. M.A. LaBarge H.M. Blau Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury Cell 111 2002 589-601
33. L.B. Balsam A.J. Wagers J.L. Christensen T. Kofidis I.L. Weissman R.C. Robbins Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium Nature 428 2004 668-673
34. C.E. Murry et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts Nature 428 2004 664-668
35. J. Abadie V. Blouin L. Guigand M. Wyers Y. Cherel Recombinant adeno-associated virus type 2 mediates highly efficient gene transfer in regenerating rat skeletal muscle Gene Ther. 9 2002 1037-1043
36. Z. Yan et al. Highly coordinated gene regulation in mouse skeletal muscle regeneration J. Biol. Chem. 278 2003 8826-8836
37. H. Kawai H. Nishino K. Kusaka T. Naruo Y. Tamaki M. Iwasa Experimental glycerol myopathy: A histological study Acta Neuropathol. (Berlin) 80 1990 192-197
38. B. Nadal-Ginard Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis Cell 15 1978 855-864
39. T. Endo B. Nadal-Ginard Three types of muscle-specific gene expression in fusion-blocked rat skeletal muscle cells: Translational control in EGTA-treated cells Cell 49 1987 515-526
40. F.E. Stockdale Eclipse of the identifiable myoblast Symp. Soc. Exp. Biol. 46 1992 1-7
41. Y. Fujio K. Guo T. Mano Y. Mitsuuchi J.R. Testa K. Walsh Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival Mol. Cell Biol. 19 1999 5073-5082
42. D.R. Alessi et al. Mechanism of activation of protein kinase B by insulin and IGF-1 EMBO J. 15 1996 6541-6551
43. S.C. Bodine et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo Nat. Cell Biol. 3 2001 1014-1019
44. C. Rommel et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways Nat. Cell Biol. 3 2001 1009-1013
45. J. Tureckova E.M. Wilson J.L. Cappalonga P. Rotwein Insulin-like growth factor-mediated muscle differentiation: Collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin J. Biol. Chem. 276 2001 39264-39270
46. A. Takahashi et al. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth Mol. Cell. Biol. 22 2002 4803-4814
47. E. Gredinger A.N. Gerber Y. Tamir S.J. Tapscott E. Bengal Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells J. Biol. Chem. 273 1998 10436-11044
48. T.A. Rando H.M. Blau Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy J. Cell Biol. 125 1994 1275-1287
49. B. Deodato et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing Gene Ther. 9 2002 777-785